A330350 logo

WITHUS PHARMACEUTICAL Co.,LTD. Stock Price

KOSDAQ:A330350 Community·₩88.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A330350 Share Price Performance

₩6,700.00
1090.00 (19.43%)
₩6,700.00
1090.00 (19.43%)
Price ₩6,700.00

A330350 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with questionable track record.

1 Risk
1 Reward

WITHUS PHARMACEUTICAL Co.,LTD. Key Details

₩102.1b

Revenue

₩36.7b

Cost of Revenue

₩65.4b

Gross Profit

₩59.1b

Other Expenses

₩6.3b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
474.31
64.01%
6.13%
22.3%
View Full Analysis

About A330350

Founded
2004
Employees
n/a
CEO
n/a
WebsiteView website
www.withuspharm.com

WITHUS PHARMACEUTICAL Co.,LTD. engages in the production and sale of pharmaceutical products in South Korea. It offers circulatory agents, endocrine cost medications, osteoporosis treatment products, antithrombotic medicines, central nervous system agents, digestive tract medications, respiratory/skin preparations, musculoskeletal medications, antibiotics, antifungal and antiviral drugs, genitourinary tract medications, psychotropic agents, and other products. The company was previously known as Withers Medipharm Co. , Ltd. and changed its name to WITHUS PHARMACEUTICAL Co.,LTD. in October 2007. WITHUS PHARMACEUTICAL Co.,LTD. was founded in 2004 and is headquartered in Seoul, South Korea.

Recent A330350 News & Updates

We Think That There Are More Issues For WITHUS PHARMACEUTICALLTD (KOSDAQ:330350) Than Just Sluggish Earnings

Nov 27
We Think That There Are More Issues For WITHUS PHARMACEUTICALLTD (KOSDAQ:330350) Than Just Sluggish Earnings

Recent updates

No updates